WO2014118649A3 - Compositions and methods for the treatment of cardiovascular diseases - Google Patents
Compositions and methods for the treatment of cardiovascular diseases Download PDFInfo
- Publication number
- WO2014118649A3 WO2014118649A3 PCT/IB2014/058090 IB2014058090W WO2014118649A3 WO 2014118649 A3 WO2014118649 A3 WO 2014118649A3 IB 2014058090 W IB2014058090 W IB 2014058090W WO 2014118649 A3 WO2014118649 A3 WO 2014118649A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- treatment
- methods
- cardiovascular diseases
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
Abstract
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for treating or preventing atherothrombosis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment or management of ischemia, stroke, cerebral thrombosis, arterial thrombosis, thrombotic cerebrovascular, cardiovascular diseases and blood clots.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN252CH2013 | 2013-01-19 | ||
IN252/CHE/2013 | 2013-01-19 | ||
IN253CH2013 | 2013-01-20 | ||
IN253/CHE/2013 | 2013-01-20 | ||
PCT/IB2013/052246 WO2013168022A1 (en) | 2012-05-08 | 2013-03-21 | Compositions and methods for treating atherothrombosis |
IBPCT/IB2013/052246 | 2013-03-21 | ||
PCT/IB2013/052328 WO2013168024A1 (en) | 2012-05-07 | 2013-03-24 | Prodrugs of anti-platelet agents |
IBPCT/IB2013/052328 | 2013-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014118649A2 WO2014118649A2 (en) | 2014-08-07 |
WO2014118649A3 true WO2014118649A3 (en) | 2017-03-23 |
Family
ID=51263080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2014/058090 WO2014118649A2 (en) | 2013-01-19 | 2014-01-07 | Compositions and methods for the treatment of cardiovascular diseases |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014118649A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111848497A (en) * | 2020-07-28 | 2020-10-30 | 内蒙古医科大学 | Clopidogrel active metabolite derivative, prodrug thereof, preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0934928A1 (en) * | 1996-08-28 | 1999-08-11 | Sankyo Company Limited | Cyclic amine derivatives |
-
2014
- 2014-01-07 WO PCT/IB2014/058090 patent/WO2014118649A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0934928A1 (en) * | 1996-08-28 | 1999-08-11 | Sankyo Company Limited | Cyclic amine derivatives |
Also Published As
Publication number | Publication date |
---|---|
WO2014118649A2 (en) | 2014-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
NZ738187A (en) | Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same | |
PH12015502443A1 (en) | 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
WO2014179564A8 (en) | Thiazolopyrrolidine inhibitors of ror-gamma | |
MX2015011077A (en) | Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders. | |
UA98373C2 (en) | Condensed heterocyclic compounds and use thereof as c-met inhibitors | |
PH12014502586A1 (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
EA201491028A1 (en) | METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES | |
WO2013175377A3 (en) | Compositions and methods for treatment of mucositis | |
WO2013175376A3 (en) | Compositions and methods for the treatment of local pain | |
WO2014172188A3 (en) | 4-pyridone derivative compounds and uses thereof as hiv integrase inhibitors | |
WO2016046680A3 (en) | Compositions and methods for the treatment of liver metabolic diseases | |
WO2014068463A3 (en) | Compositions and methods for the treatment of inflammation and metabolic disorders | |
MX2019003912A (en) | Compositions and methods for the treatment of xerostomia. | |
WO2013175359A3 (en) | Compositions and methods for the treatment of multiple sclerosis | |
MX2017013099A (en) | Methods for the treatment of inflammatory disorders. | |
WO2014091384A3 (en) | Compositions and methods for the treatment of mucositis | |
MX2022005523A (en) | Compositions and methods for the treatment of fungal infections. | |
WO2014006529A3 (en) | Compositions and methods for the treatment of moderate to severe pain | |
MX2019006163A (en) | Compositions and methods for the treatment of oral infectious diseases. | |
WO2014108336A8 (en) | Pyrazolyl-based carboxamides ii as crac channel inhibitors | |
EA201492256A1 (en) | PROCARE OF 5- (5-PHENYL-4- (Pyridine-2-Ilmethylamino) Quinazoline-2-IL) Pyridine-3-Sulfonamide Based on Phosphoramide Acid | |
WO2014087323A3 (en) | Compounds and compositions for the treatment of autoimmune and chronic metabolic diseases | |
WO2014097137A3 (en) | Compositions and methods for the treatment of seizures and neurologic diseases | |
WO2014118649A3 (en) | Compositions and methods for the treatment of cardiovascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14746913 Country of ref document: EP Kind code of ref document: A2 |